大概整理了一下11月10号至12号要发布的新作…感觉是有些夸张的程度
Taylor Swift - Red(Taylor’s Version)
Silk Sonic - An Evening With Silk Sonic
Avril Lavigne - Bite Me
金韩彬 - COSMOS
TWICE - Formula of Love: O+T=<3
Chris Lake / Grimes - Love Is A Drug From God
Gracie Abrams - This
Taylor Swift - Red(Taylor’s Version)
Silk Sonic - An Evening With Silk Sonic
Avril Lavigne - Bite Me
金韩彬 - COSMOS
TWICE - Formula of Love: O+T=<3
Chris Lake / Grimes - Love Is A Drug From God
Gracie Abrams - This
大概整理了一下11月10号至12号要发布的新作…感觉是有些夸张的程度
Taylor Swift - Red(Taylor’s Version)
Silk Sonic - An Evening With Silk Sonic
Avril Lavigne - Bite Me
金韩彬 - COSMOS
TWICE - Formula of Love: O+T=<3
Chris Lake / Grimes - Love Is A Drug From God
Gracie Abrams - This Is What It Feels Like
Kylie Minogue - Disco: Guest List Edition
Ariana Grande - r.e.m. beauty
Taylor Swift - Red(Taylor’s Version)
Silk Sonic - An Evening With Silk Sonic
Avril Lavigne - Bite Me
金韩彬 - COSMOS
TWICE - Formula of Love: O+T=<3
Chris Lake / Grimes - Love Is A Drug From God
Gracie Abrams - This Is What It Feels Like
Kylie Minogue - Disco: Guest List Edition
Ariana Grande - r.e.m. beauty
#全球抗疫#辉瑞抗新冠病毒药物效果更好?
辉瑞提前终止了抗新冠病毒新药的3期临床试验,因为目前获得的数据提示该可以降低感染新冠病毒后患重症或死亡之89%的风险,这一结果似乎较默克制药的抗新冠病毒“神药”效果更佳哈。
Nov 5 (Reuters) - A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.
The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness.
辉瑞提前终止了抗新冠病毒新药的3期临床试验,因为目前获得的数据提示该可以降低感染新冠病毒后患重症或死亡之89%的风险,这一结果似乎较默克制药的抗新冠病毒“神药”效果更佳哈。
Nov 5 (Reuters) - A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.
The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness.
✋热门推荐